Top

Published in:

01-09-2011 | Review

A systematic review of quality of life in adults with muscle disease

Authors: Christopher D. Graham, Michael R. Rose, Elizabeth A. Grunfeld, Simon D. Kyle, John Weinman

Published in: Journal of Neurology | Issue 9/2011

Abstract

We reviewed the literature on how muscle disease affects quality of life compared to healthy controls, and the factors that influence the effects of muscle disease on quality of life. We also wanted to know whether quality of life differed between muscle diseases. We searched online databases and identified 26 relevant studies. The quality of each study was assessed, results sections analysed and a database of factors associated with quality of life developed. We graded the level of evidence supporting the association between each factor and quality of life as inconclusive, moderate or high. Compared to controls, muscle disease compromised quality of life in all areas of functioning. There was little evidence to suggest that quality of life differed significantly between muscle diseases. There was a high level of evidence suggesting that disease severity, pain, fatigue, and mood significantly affect quality of life. There was a moderate level of evidence suggesting that illness perceptions, coping strategies, age and gender affect quality of life. Several factors had an inconsistent level of evidence.

World Health Organization. Available at: http://www.who.int/en/. Accessed May 19

Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I Conceptual framework and item selection. Med Care 30(6):473–483PubMedCrossRef

Bergner M, Bobbitt RA (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19(8):787–805PubMedCrossRef

Hunt SM, McKenna SP, McEwen J (1981) The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med Part A Med Sociol 15(3-I):221–229CrossRef

Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR (2007) Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 68(13):1051–1057PubMedCrossRef

Kalkman JS, Schillings ML, van der Werf SP et al (2005) Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 76(10):1406–1409PubMedCrossRef

Rose MR, Sadjadi R, Weinman J, Akhtar T, Pandya S, Kissel JT, Jackson CE (2011) The role of disease severity, illness perceptions and mood on quality of life in chronic muscle disease. (Submitted)

Kalkman JS, Schillings ML, Zwarts MJ et al (2007) The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 62(5):571–579PubMedCrossRef

Padua L, Aprile I, Frusciante R et al (2009) Quality of life and pain in patients with facioscapulohumeral muscular dystrophy. Muscle Nerve 40(2):200–205PubMedCrossRef

10.

Albrecht GL, Devlieger PJ (1999) The disability paradox: high quality of life against all odds. Soc Sci Med 48(8):977–988PubMedCrossRef

11.

Gerhart KA, Koziao-McLain J, Lowenstein SR, Whiteneck GG (1994) Quality of life following spinal cord injury: knowledge and attitudes of emergency care providers. Ann Emerg Med 23(4):807–812PubMedCrossRef

12.

Abresch RT, Seyden NK, Wineinger MA (1998) Quality of life. Issues for persons with neuromuscular diseases. Phys Med Rehabil Clinics North Am 9:233–248

13.

Sadjadi R, Rose MR (2010) Muscle Study Group. What determines quality of life in inclusion body myositis? J Neurol Neurosurg Psychiatry 81:1164–1166PubMedCrossRef

14.

Kmet LM, Lee RC, Cook LS (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research, Alberta

15.

Antonini G, Soscia F, Giubilei F et al (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38(3):181–185PubMedCrossRef

16.

Grootenhuis MA, de Boone J, van der Kooi AJ (2007) Living with muscular dystrophy: health related quality of life consequences for children and adults. Health Quality Life Outcomes 5:31CrossRef

17.

Ford C, Kidd A, Hammond-Tooke G (2006) Myotonic dystrophy in Otago, New Zealand. N Z Med J 119(1241):U2145PubMed

18.

Bronner IM, van der Meulen MF, de Visser M et al (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65:1456–1461PubMedCrossRef

19.

Bostrom K, Ahlstrom G (2005) Quality of life in patients with muscular dystrophy and their next of kin. Int J Rehabil Res 28(2):103–109PubMedCrossRef

20.

Oksuz C, Kilinc M, Yildirim SA (2009) Predictors of health-related quality of life in adult ambulatory independence neuromuscular disease patients. Neurosciences 14(4):355–359PubMed

21.

Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology 44:83–88PubMedCrossRef

22.

Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology 41:22–26PubMedCrossRef

23.

Bostrom K, Natterlund BS et al (2005) "Sickness impact in people with muscular dystrophy: a longitudinal study over 10 years." Clin Rehabil 19(6):686–694

24.

Ahlstrom G, Gunnarsson L (1996) Disability and quality of life in individuals with muscular dystrophy. Scand J Rehabil Med 28(3):147–157PubMed

25.

Piccininni M, Falsini C, Pizzi A (2004) Quality of life in hereditary neuromuscular diseases. Acta Neurol Scand 109(2):113–119PubMedCrossRef

26.

Ahlstrom G, Gunnarsson L-G, Kihlgren A, Arvill A, Sjödén P-O (1994) Respiratory function, electrocardiography and quality of life in individuals with muscular dystrophy. Chest 106(1):173–179PubMedCrossRef

27.

Sansone VA, Panzeri M, Montanari M et al (2010) Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases. Eur J Neurol 17(9):1178–1187PubMedCrossRef

28.

Hundley JL, Carroll CL, Lang W et al (2006) Cutaneous symptoms of dermatomyositis significantly impact patients’ quality of life. J Am Acad Dermatol 54:217–220PubMedCrossRef

29.

Laberge L, Dauvilliers Y, Begin P, Richer L, Jean S, Mathieu J (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromuscul Disord 19(6):397–402

30.

Miro J, Raichle KA, Carter GT et al (2009) Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Hospice Palliative Med 26(4):308–319CrossRef

31.

Abresch RT, Carter GT, Jensen MP, Kilmer DD (2002) Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hospice Palliative Med 19(1):39–48CrossRef

32.

Ahlstrom G, Sjoden PO (1996) Coping with illness-related problems and quality of life in adult individuals with muscular dystrophy. J Psychosom Res 41(4):365–376PubMedCrossRef

33.

Nätterlund B, Gunnarsson L-G, Ahlström G (2000) Disability, coping and quality of life in individuals with muscular dystrophy: a prospective study over five years. Disabil Rehabil 22(17):776–785

34.

Minis MA, Kalkman JS, Akkermans RP et al (2010) Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis. J Rehabil Med 42(1):60–65PubMedCrossRef

35.

Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17(1):1–16CrossRef

36.

Natterlund B, Ahlstrom G (2001) Activities of daily living and quality of life in persons with muscular dystrophy. J Rehabil Med 33(5):206–211PubMedCrossRef

37.

Koch T (2000) Life quality vs the ‘quality of life’: assumptions underlying prospective quality of life instruments in health care planning. Soc Sci Med 51(3):419–427PubMedCrossRef

38.

Natterlund B, Sjoden PO, Ahlstrom G (2001) The illness experience of adult persons with muscular dystrophy. Disabil Rehabil 23(17):788–798PubMedCrossRef

39.

Kohler M, Clarenbach CF, Böni L, Brack T, Russi EW, Bloch KE (2005) Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med 172(8):1032–1036PubMedCrossRef

40.

Gibson B (2001) Long-term ventilation for patients with Duchenne muscular dystrophy: physicians’ beliefs and practices. Chest 119(3):940–946PubMedCrossRef

41.

Jensen MP, Abresch RT, Carter GT, McDonald CM (2005) Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil 86(6):1155–1163PubMedCrossRef

42.

Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM (2008) Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 89(2):320–328PubMedCrossRef

43.

Schillings ML, Kalkman JS, Janssen HM, van Engelen BG, Bleijenberg G, Zwarts MJ (2007) Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 118(2):292–300PubMedCrossRef

44.

Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 69(3):308–312PubMedCrossRef

45.

Schrag A, Jahanshahi M, Quinn N (2000) How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 15(6):1112–1118PubMedCrossRef

46.

Ravina B, Camicioli R, Como PG et al (2007) The impact of depressive symptoms in early Parkinson disease. Neurology 69(4):342–347PubMedCrossRef

47.

Melo M, Lauriano V, Gentil V et al (1995) Becker and limb-girdle muscular dystrophies: a psychiatric and intellectual level comparative study. Am J Med Genet Neuropsychiatric Genet 60(1):33–38CrossRef

48.

Bungener C, Jouvent R, Delaporte C (1998) Psychopathological and emotional deficits in myotonic dystrophy. J Neurol Neurosurg Psychiatry 65(3):353–356PubMedCrossRef

49.

Brorsson B, Ifver J, Hays RD (1993) The Swedish health-related quality of life survey (SWED-QUAL). Qual Life Res 2(1):33–45PubMedCrossRef

50.

Michelson H, Bolund C, Nilsson B, Brandberg Y (2000) Health-related quality of life measured by the EORTC QLQ-C30–reference values from a large sample of Swedish population. Acta Oncol 39(4):477–484PubMedCrossRef

51.

Hagger MS, Orbell S (2003) A meta-analytic review of the common-sense model of illness representations. Psychol Health 18(2):141–184CrossRef

52.

Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J (2002) Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 64(4):580–586PubMed

Title: A systematic review of quality of life in adults with muscle disease
Authors: Christopher D. Graham
Michael R. Rose
Elizabeth A. Grunfeld
Simon D. Kyle
John Weinman
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 9/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6062-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A systematic review of quality of life in adults with muscle disease

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2011

Unilateral hemispheric primary angiitis of the central nervous system

News on ion channels: erythromelalgia, treatment of episodic ataxia and faciobrachial dystonic seizures

Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication

Longitudinal study on MRI intensity changes of Machado–Joseph disease: correlation between MRI findings and neuropathological changes

Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study

Steady or not following thalamic deep brain stimulation for essential tremor